Carboxypeptidases inhibition

The effects of various enzymes on the activity of HPLC fractions that inhibited 3H-PCP binding were investigated. As shown in table 1, pronase (0.5 pg/ml), carboxypeptidase A (0.1 unit/ml), and trypsin (3.0 g/ml ) markedly decreased the potency of 10 n units of PCP-like activity. No significant change in activity was. seen when fractions were incubated with alpha-chymotrypsin. 

Peptidyl-dipeptidase A (angiotensin-I converting enzyme, ACE, EC 3.4.15.1) plays a pivotal role in the control of blood pressure [80]. It has been established that its active site contains an essential Zn-atom that functions like that of carboxypeptidase A [2], ACE is inhibited by peptides having a proline or aromatic amino acid at the C-terminal position. These observations as well as the similarities with the active site of carboxypeptidase A have allowed a rational design of effective inhibitors of ACE (e.g., captopril (3.4) and enalapril (3.5)) used in the treatment of hypertension [81]. 

A novel concept of using bioadhesive polymers as enzyme inhibitors has been developed [97]. Included are derivatives of poly acrylic acid, polycarbophil, and car-bomer to protect therapeutically important proteins and peptides from proteolytic activity of enzymes, endopeptidases (trypsin and a-chymotrypsin), exopeptidases (carboxypeptidases A and B), and microsomal and cytosolic leucine aminopeptidase. However, cysteine protease (pyroglutamyl aminopeptidase) is not inhibited by polycarbophil and carbomer [97]. 

This enzyme [EC 3.4.16.4], also known as serine-type D-alanyl-D-alanine carboxypeptidase, catalyzes the hydrolysis of D-alanyl-D-alanine to yield two D-alanine. This enzyme comprises a group of membrane-bound, bacterial enzymes of the peptidase family Sll. They are distinct from the zinc D-alanyl-D-alanine carboxypeptidase [EC 3.4.17.14]. The enzyme also hydrolyzes the D-alanyl-D-alanine peptide bond in the polypeptide of the cell wall. In addition, the enzyme will also catalyze the transpeptidation of peptidyl-alanyl moieties that are A-acetyl-substituents of D-alanine. The protein is inhibited by j8-lactam antibiotics, which acylate the active-site seryl residue. 

This enzyme [EC 3.4.16.5] (also known as serine-type carboxypeptidase I, cathepsin A, carboxypeptidase Y, and lysosomal protective protein) is a member of the peptidase family SIO and catalyzes the hydrolysis of the peptide bond, with broad specificity, located at the C-terminus of a polypeptide. The pH optimum ranges from 4.5 to 6.0. The enzyme is irreversibly inhibited by diisopropyl fluorophosphate and is sensitive to thiolblocking reagents. 

Fig. 35. The phosphonate analog of the carboxypeptidase A substrate Cbz-Ala-Ala-Phe inhibits the enzyme with a /fj of 3 pM (Hanson et al, 1989) and binds with unidentate phosphinyl-zinc coordination, as revealed in an X-ray crystallographic study (Kim and Lipscomb, 1990). Stippled density shows the refined positions of zinc and phosphorus. [Reprinted with permission from Kim, H., Lipscomb, W. N. (1990) Biochemistry 29, 5546-5555. Copyright 1990 American Chemical Society.]...

Zinc metalloproteases can be inhibited by fluoroketones. This inhibition should stem from complexation of the monoanion of the fluoroketone hydrate with zinc. Thus, S-amido and peptidyl fluoroketones inhibit carboxypeptidase and microbial... 

Blanco-Aparicio, C., Molina, M. A., Femandez-Salas, E., Frazier, M. L., Mas, J. M., Querol, E., Aviles, F. X., de Llorens, R. (1998). Potato carboxypeptidase inhibitor, a T-knot protein, is an epidermal growth factor antagonist that inhibits tumor cell growth. J. Biol. Chem., 273, 12370-12377. 

Little is known about the regulation mechanisms of the synthesis of complex carbohydrate in plants, through lipid intermediates. However, partial evidence indicates that lipid-mediated glycosylation in proteins could be a regulatory step. When glycosylation of carboxypeptidase Y is inhibited... 

The carboxypeptidases are released from their inactive precursors in the pancreatic juice of animals. The most studied example is bovine carboxypeptidase A, which contains one mole of zinc per protein molecular weight of 34 500. These enzymes cleave the C-terminal amino acid residue from peptides and proteins, when the side-chain of the C-terminal residue is aromatic or branched aliphatic of l configuration. At least the first five residues in the substrate affect the activity of the enzyme. The enzyme also shows esterase activity. Esters and peptides inhibit each other competitively, indicating that the peptidase and esterase sites overlap, even if they are not the same. 

In the presence of a large excess of Co2+, both native (97) and cobalt (92) carboxypeptidase A show an approximately two-fold activity increase. The kinetics of the enzyme are very complex at moderate or high substrate concentrations and involve both apparent activation and inhibition by substrate (95). Under the standard assay conditions used in connection with the observed cobalt activation, all these complicating factors contribute significantly. The additional Co2+ possibly interferes with these secondary effects rather than being a participant in catalysis. Further experimentation is needed to clarify this detail. 

In in vitro studies penicillamine inhibited angiotensin-con-verting enzyme (ACE) and carboxypeptidase (930). Penicillamine interferes with the functions of the copper-containing enzyme ceruloplasmin, and some of the penicillamine- and copper-containing complexes formed in vivo have a superoxide dismutase effect (931). In patients with scleroderma, penicillamine normalized collagen metabolism, by inhibiting beta-galactosidase activity (932). 

Thrombin activable fibrinolysis inhibitor (TAFI) is a plasma protein that is activated by thrombin in the presence of thrombomodulin to a labile carboxypeptidase-B-like enzyme that inhibits fibrinolysis. When TAFIa is included in a clot undergoing lysis induced by tPA and plasminogen, the time to achieve lysis is prolonged and free lysine and arginine are released (Wang et al., 1998). TAFIa retards the fibrin-enhanced activation of plasminogen by tPA and inhibits the accumulation of plasminogen at the lysis front (Sakharov et al., 1997). 

E. Gustavsson, P. Bjurling and A. Sternesjo, Biosensor analysis of penicillin G in milk based on the inhibition of carboxypeptidase activity, Anal. Chim. Acta, 468 (2002) 153-159. 

---